Affordability
NUZYRA is covered by a majority of insurers in the United States with limited or no restrictions1
Broad insurance coverage plus patient and provider resources help facilitate timely prescription fulfillment.
After submission of all necessary information, most ePAs are approved in 24 hours or less.1
Powered by
Using CoverMyMeds® can assist in determination of PAs and tracking of submitted and pending PAs.
ePA=electronic prior authorization.
Insurance coverage and reimbursement for NUZYRA are not guaranteed. Coverage and reimbursement depend on an individual patient’s insurance plan. We recommend that you contact the insurance provider to verify NUZYRA coverage and reimbursement. Certain factors like personal insurance and/or deductibles may impact the price of your prescription.
With the NUZYRA Copay Program, the majority of eligible commercially insured patients may pay as little as $0.*
*Terms and conditions applyInsurers
| Commercial | When a prior authorization is required, our specialty pharmacy partners are here to help. |
| Medicare Advantage/ Supplemental | Specialty pharmacy will work with providers and patients on prior authorization, if required. Covered with a lower out-of-pocket cost than traditional Medicare Part D. Out-of-pocket costs will vary based on the design of the plan. |
| Basic Medicare | Individuals enrolled in basic Medicare plan may have high out-of-pocket costs for their prescription. |
| Medicaid | Some states may require documented failure on 1 or 2 antibiotics with clinical notes. |
| Low-income Subsidy | Specialty pharmacy will work with providers and patients on prior authorization, if required. Covered with low out-of-pocket cost. |
| Tricare |
With prior authorization, there is no copay for active-duty service members at a military treatment facility. No prior authorization required if filled through our Specialty Pharmacy Network, however there is a $76 copay. |
NUZYRA Bridge Program
Provides eligible patients up to a 2-day supply of NUZYRA tablets in the event there is a delay in coverage during the benefits investigation with the patient’s insurance.
Explore more patient services with NUZYRA SurePath™